| 7439356 |
Substituted indan derivatives |
Stefan Berg, Lennart Florvall, Svante Ross |
2008-10-21 |
$12,560,000 |
| 7384943 |
Substituted chroman derivatives |
Stefan Berg, Martin Nylof, Svante Ross |
2008-06-10 |
$5,253,000 |
| 7056921 |
Substituted chroman derivatives |
Stefan Berg, Martin Nylof, Svante Ross |
2006-06-06 |
$12,341,000 |
| 6670359 |
Substituted chroman derivatives |
Stefan Berg, Martin Nylof, Svante Ross |
2003-12-30 |
$18,737,000 |
| 6548498 |
Substituted indan derivatives |
Stefan Berg, Lennart Florvall, Svante Ross |
2003-04-15 |
$7,624,000 |
| 6534652 |
Intermediates for the preparation of substituted 1,2,3,4-tetrahydronaphthalene derivatives |
Stefan Berg, Svante Ross |
2003-03-18 |
$30,300,000 |
| 6479497 |
Substituted chroman derivatives |
Stefan Berg, Martin Nylof, Svante Ross |
2002-11-12 |
$6,401,000 |
| 6472423 |
Pharmaceutical composition |
Svante Ross |
2002-10-29 |
$14,987,000 |
| 6410530 |
Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
Stefan Berg, Lennart Florvall, Svante Ross |
2002-06-25 |
$8,476,000 |
| 6410532 |
Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
Stefan Berg, Mats Linderberg, Svante Ross, Bengt Ulff |
2002-06-25 |
$8,476,000 |
| 6387899 |
Substituted chroman derivatives |
Stefan Berg, Mats Linderberg, Svante Ross, Bengt Ulff |
2002-05-14 |
$13,320,000 |
| 6384225 |
Intermediates in the preparation of substituted chroman derivatives |
Stefan Berg, Mats Linderberg, Svante Ross, Bengt Ulff |
2002-05-07 |
$6,517,000 |
| 6313118 |
Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
Stefan Berg, Mats Linderberg, Svante Ross, Bengt Ulff |
2001-11-06 |
|
| 6184219 |
Composition and methods employing it for the treatment of 5-HT-mediated disorders |
John Evenden |
2001-02-06 |
|
| 6184218 |
Composition and methods employing it for the treatment of 5-HT-mediated disorders |
John Evenden |
2001-02-06 |
|
| 6172105 |
Composition and methods employing it for the treatment of 5-HT-mediated disorders |
John Evenden |
2001-01-09 |
|
| 6169098 |
Composition and methods employing it for the treatment of 5-HT-mediated disorders |
John Evenden |
2001-01-02 |
|
| 6159971 |
Combination of a 5-HT reuptake inhibitor and a H5-HT1B anatagonist or partial agonist |
Stefan Berg, Svante Ross |
2000-12-12 |
$8,539,000 |
| 6159970 |
Combination of a monoamine oxidase inhibitor and a h5-HT.sub.1B antagonist or partial agonist |
Stefan Berg, Svante Ross |
2000-12-12 |
$8,539,000 |
| 6159972 |
Combination of a selective 5-HT.sub.1A antagonist and a selective ub . h5-HT.s1B antagonist or partial agonist |
Stefan Berg, Svante Ross |
2000-12-12 |
$8,539,000 |
| 6124283 |
Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
Stefan Berg, Lennart Florvall, Svante Ross |
2000-09-26 |
|
| 5962514 |
Combination of 5-HT uptake inhibitor with a selective 5-HT1A antagonist |
John Evenden |
1999-10-05 |
|
| 5656657 |
Chroman derivatives |
Eva Maria Hammarberg, Lars George Johansson, Lars-Gunnar Larsson, Rolf Noreen, Lucy Anna Renyi +3 more |
1997-08-12 |
|
| 5656658 |
Method for the treatment of anxiety |
Eva Maria Hammarberg, Lars George Johansson, Lars-Gunnar Larsson, Rolf Noreen, Lucy Anna Renyi +3 more |
1997-08-12 |
|
| 5646309 |
Intermediates in the synthesis of chroman derivatives |
Eva Maria Hammarberg, Lars George Johansson, Lars-Gunnar Larsson, Rolf Noreen, Lucy Anna Renyi +3 more |
1997-07-08 |
|
